Gilead Named One of America’s Most JUST Companies by JUST Capital and CNBC
09 Febrero 2024 - 10:00AM
Business Wire
– Company Also Ranked in Top 5 of
Pharmaceuticals and Biotech Industry –
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the company
has been named one of America’s Most JUST Companies. The ranking,
presented by JUST Capital and CNBC, reflects Gilead’s longstanding
commitment to operate responsibly by prioritizing stakeholder
engagement – including with the patients and communities the
company serves, employees and shareholders – while working to
create a healthier world for all people. Gilead was recognized on
the top 100 list and ranked fifth in the Pharmaceuticals and
Biotech industry.
“We have set ambitious goals that are helping to further embed
corporate responsibility into our business and honor our commitment
to create a better world for future generations,” said Carmen
Villar, Vice President, Public Affairs, Gilead Sciences. “We are
proud to cultivate sustainable practices and an inclusive culture,
while providing equitable opportunities for the communities we
serve.”
Gilead’s Environmental, Social and Governance (ESG) strategy
aims to position the company as the biotech employer and partner of
choice while delivering shareholder value in a sustainable,
responsible manner. Examples of Gilead’s commitment to ESG
include:
- Expanding health equity around the world through programs that
promote health system sustainability, strengthen infrastructure and
provide education and financial support
- Increasing access to medicines in low- and lower-middle income
countries, including voluntary licensing for Gilead’s HIV,
hepatitis C and COVID-19 treatments
- Creating an inclusive workplace that is representative of the
diverse communities the company serves
- Continuing to evolve the company’s environmental sustainability
program while progressing against ambitious goals focused on
carbon, water, waste and packaging
Each year, JUST Capital collects and analyzes corporate data to
evaluate the 1,000 largest public U.S. companies across 20 issues
identified through comprehensive, ongoing public opinion research
on Americans’ attitudes toward responsible corporate behavior. For
more about the JUST Capital rankings, visit:
https://justcapital.com/reports/just-capital-and-cnbc-release-the-2024-rankings-of-americas-most-just-companies/
This recognition follows Gilead’s recent announcement it was
named to the Dow Jones Sustainability World Index for the third
consecutive year, as well as the Dow Jones Sustainability North
America Index, which highlight the most sustainable companies
around the world based on a corporate sustainability
assessment.
Details on Gilead’s ESG commitments, goals and progress can be
found in the company’s Environmental Social Governance Impact
Report, which is based on internationally recognized guidelines
from the Global Reporting Initiative, the Sustainability Accounting
Standards Board, the Taskforce on Climate Related Financial
Disclosures and the United Nations Sustainable Development Goals.
Learn more about Gilead’s commitment to ESG at
https://www.gilead.com/purpose/esg.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has
pursued and achieved breakthroughs in medicine for more than three
decades, with the goal of creating a healthier world for all
people. The company is committed to advancing innovative medicines
to prevent and treat life-threatening diseases, including HIV,
viral hepatitis, COVID-19, and cancer. Gilead operates in more than
35 countries worldwide, with headquarters in Foster City,
California.
Gilead and the Gilead logo are registered
trademarks of Gilead Sciences, Inc., or its related companies.
For more information about Gilead, please visit
the company’s website at www.gilead.com, follow Gilead on X/Twitter
(@Gilead Sciences) and LinkedIn (@Gilead-Sciences).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240208075998/en/
Jacquie Ross, Investors investor_relations@gilead.com
Meaghan Smith, Media public_affairs@gilead.com
Gilead Sciences (NASDAQ:GILD)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Gilead Sciences (NASDAQ:GILD)
Gráfica de Acción Histórica
De May 2023 a May 2024